Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Australian Pharmaceutical Industries Limited    API   AU000000API4

AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED

(API)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
01/19/2021 01/20/2021 01/21/2021 01/22/2021 01/25/2021 Date
1.23 1.235 1.22 1.225 1.245 Last
464459 432390 458471 495135 292109 Volume
+2.93% +0.41% -1.21% +0.41% +1.63% Change
Financials
Sales 2021 3 991 M 3 071 M 3 071 M
Net income 2021 35,3 M 27,2 M 27,2 M
Net Debt 2021 61,5 M 47,3 M 47,3 M
P/E ratio 2021 18,0x
Yield 2021 3,92%
Sales 2022 4 082 M 3 141 M 3 141 M
Net income 2022 41,3 M 31,8 M 31,8 M
Net Debt 2022 85,9 M 66,1 M 66,1 M
P/E ratio 2022 14,5x
Yield 2022 4,97%
Capitalization 613 M 472 M 472 M
EV / Sales 2021 0,17x
EV / Sales 2022 0,17x
Nbr of Employees -
Free-Float 97,7%
More Financials
Company
Australian Pharmaceutical Industries Limited is a pharmaceutical distributor, and health and beauty retailer. The Company operates through two segments: Australia, which is engaged in the distribution of pharmaceutical, medical, health, beauty and lifestyle products to pharmacies, the purchase and sale of various health, beauty and lifestyle products within the retail industry, and the provision of retail services... 
More about the company
Notations Surperformance© of Australian Pharmaceutical Industries Limited
Trading Rating : Investor Rating :
More Ratings
All news about AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED
2020AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Ex-dividend day for final dividend
FA
2019SIGMA HEALTHCARE : Farewells API, Heralds New Contract
AQ
2019AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Ex-dividend day for final dividend
FA
2019AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Ex-dividend day for interim dividend
FA
2018AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Ex-dividend day for final dividend
FA
2018AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Ex-dividend day for interim dividend
FA
2017AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Ex-dividend day for final dividend
FA
2017AUSTRALIAN PHARMACEUTICAL INDUSTRIES : annual earnings release
2017AUSTRALIAN PHARMACEUTICAL INDUSTRIES : API) talks growing distribution and retai..
FI
2017AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Ex-dividend day for interim dividend
FA
2017AUSTRALIAN PHARMACEUTICAL INDUSTRIES : half-yearly earnings release
2016AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Ex-dividend day for final dividend
FA
2016AUSTRALIAN PHARMACEUTICAL INDUSTRIES : API): ASX Spotlight Series, Hong Kong
FI
2016AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Ex-dividend day for interim dividend
FA
2016AUSTRALIAN PHARMACEUTICAL INDUSTRIES : ASX Spotlight Series March 2016, New York
FI
More news
News in other languages on AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED
2017AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Veröffentlichung des Jahresergebnisses
2017AUSTRALIAN PHARMACEUTICAL INDUSTRIES : publication des résultats annuels
2017AUSTRALIAN PHARMACEUTICAL INDUSTRIES : publication des résultats semestriels
2017AUSTRALIAN PHARMACEUTICAL INDUSTRIES : Veröffentlichung des Halbjahresergebnisse..
More news
Chart AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Australian Pharmaceutical Industries Limited Technical Analysis Chart | API | AU000000API4 | MarketScreener
Technical analysis trends AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 1,30 AUD
Last Close Price 1,25 AUD
Spread / Highest target 20,5%
Spread / Average Target 4,02%
Spread / Lowest Target -15,7%
EPS Revisions
Managers and Directors
NameTitle
Richard Craig Vincent Chief Executive Officer, MD & Executive Director
Kenneth William Gunderson-Briggs Chairman
Peter Mendo Chief Financial Officer
Dean D. Matthews Chief Information Officer
Lee Ausburn Independent Non-Executive Director